Keyphrases
Pneumococcal Conjugate Vaccine
73%
Streptococcus Pneumoniae
62%
PCV7
54%
Otitis Media
54%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
50%
Southern Israel
45%
Invasive Pneumococcal Disease
42%
Pneumonia
37%
Israel
34%
Community-acquired
30%
Young children
28%
S. Pneumoniae
25%
Bedouin children
23%
Nasopharyngeal Carriage
21%
Pneumococcal Carriage
21%
Vaccine Serotypes
20%
Pneumococcal Serotypes
19%
Jewish children
19%
7-valent
16%
Pneumococcus
15%
Streptococcus Pneumoniae Serotypes
15%
Toddlers
14%
Serotype-specific
14%
NTHi
13%
Antibiotics
12%
Nasopharyngeal
12%
Carriage Rate
12%
Conjugate Vaccine
11%
Daycare Centers
11%
Antibiotic Resistant
11%
Vaccination
10%
Vaccine Introduction
10%
Respiratory Syncytial Virus
10%
Confidence Interval
10%
Bedouin
10%
Rotavirus
10%
Serotype Replacement
10%
Antibiotic Use
10%
Pneumococcal Disease
10%
Pediatric
9%
Incidence Rate
9%
Haemophilus Influenzae
9%
Serotype 6A
8%
Pneumococcal Vaccine
8%
Non-susceptible
8%
13-valent
8%
9-valent
8%
Nasopharyngeal Microbiota
8%
COVID-19
8%
IgG Concentration
7%
Medicine and Dentistry
Serotype
76%
Pneumococcus Vaccine
63%
Streptococcus Pneumoniae
52%
Acute Otitis Media
31%
Pneumococcal Infection
29%
Disease
27%
Toddlers
26%
Antibiotics
25%
Pediatrics
20%
Otitis Media
15%
Pneumococcus
13%
Conjugate Vaccine
12%
Infection
9%
Human Respiratory Syncytial Virus
8%
Rotavirus
7%
Community-Acquired Pneumonia
7%
Antibiotic Resistance
7%
Pathogen
6%
Lower Respiratory Tract Infection
6%
Middle Ear
6%
COVID-19
5%
Respiratory Tract Infection
5%
Prevalence
5%
Prospective Study
5%
Seasonal Variation
5%
Haemophilus influenzae
5%
Immunology and Microbiology
Serotype
100%
Pneumococcal Vaccine
71%
Streptococcus Pneumoniae
65%
Vaccine Efficacy
37%
Otitis Media
30%
Pneumococcus
17%
Vaccination Policy
14%
Dynamics
11%
Haemophilus influenzae
10%
Nontypeable Haemophilus Influenzae
9%
Antimicrobial Resistance
8%
Conjugate Vaccine
7%
Prevalence
7%
Conjunctivitis
7%
Human Respiratory Syncytial Virus
6%
Infectious Agent
6%
Lineages
6%
Rotavirus
5%
Antibody Blood Level
5%
Monospecific Antibody
5%
Moraxella catarrhalis
5%